Akero Therapeutics Inc

NASDAQ:AKRO  
29.18
+0.33 (+1.14%)
Earnings Announcements

Akero Therapeutics Reports Q3 2020 Financial Results

Published: 11/12/2020 21:44 GMT
Akero Therapeutics Inc (AKRO) - Akero Therapeutics Reports Third Quarter 2020 Financial Results.
Qtrly Loss per Share $0.63.
Q3 Earnings per Share View $-0.65 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.60

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.52

More details on our Analysts Page.